Shanghai Fosun Pharmaceutical (Group) Co., Ltd. sold $145k of NATR
owner at NATURES SUNSHINE PRODUCTS INC. 10,895 shares at an average of $13.33, traded Oct 1, 2024, filed Oct 15, 2024.
Score components
- +12Role10% owner
- +11Trade size$145k at market
- +5Share of holdings soldSold 14% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +23.8%, 3m +8.4%, 6m -6.7%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-24-108390, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 6, 2024 | JOther Common Stockindirect: by Fosun Industrial Co., Limited | +2,968 | $0.00 | $0 | 77,362 | Oct 15, 2024 |
| Oct 1, 2024 | SOpen-market sale Common Stockindirect: by Fosun Industrial Co., Limited | -1,399 | $13.54 | $19k | 75,963 | Oct 15, 2024 |
| Oct 8, 2024 | SOpen-market sale Common Stockindirect: by Fosun Industrial Co., Limited | -1,800 | $13.13 | $24k | 74,163 | Oct 15, 2024 |
| Oct 9, 2024 | SOpen-market sale Common Stockindirect: by Fosun Industrial Co., Limited | -1,816 | $13.36 | $24k | 72,347 | Oct 15, 2024 |
| Oct 10, 2024 | SOpen-market sale Common Stockindirect: by Fosun Industrial Co., Limited | -3,000 | $13.39 | $40k | 69,347 | Oct 15, 2024 |
| Oct 11, 2024 | SOpen-market sale Common Stockindirect: by Fosun Industrial Co., Limited | -1,580 | $13.37 | $21k | 67,767 | Oct 15, 2024 |
| Oct 14, 2024 | SOpen-market sale Common Stockindirect: by Fosun Industrial Co., Limited | -1,300 | $13.12 | $17k | 66,467 | Oct 15, 2024 |
Related signals
Other insiders at NATURES SUNSHINE PRODUCTS INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 21Weak | NATRsell NATURES SUNSHINE PRODUCTS INC | Bryant J Yates EVP & President, Europe | $38k 1,700 shares | -2% | |
| 40Moderate | NATURES SUNSHINE PRODUCTS INC | Jonathan David Lanoy SVP, Chief Accounting Officer | $102k 5,000 shares | -10% | |
| 47Moderate | NATURES SUNSHINE PRODUCTS INC | Daniel C Norman EVP & President, Asia | $182k 8,884 shares | -12% | |
| 39Weak | NATURES SUNSHINE PRODUCTS INC | Nathan G Brower EVP, General Counsel | $79k 3,800 shares | -8% | |
| 41Moderate | NATURES SUNSHINE PRODUCTS INC | Bryant J Yates EVP & President, Europe | $162k 9,672 shares | -9% | |
| 46Moderate | NATURES SUNSHINE PRODUCTS INC | Nathan G Brower EVP, General Counsel | $165k 9,996 shares | -17% | |
| 39Weak | NATURES SUNSHINE PRODUCTS INC | Jonathan David Lanoy SVP, Chief Accounting Officer | $83k 5,000 shares | -9% | |
| 57Moderate | NATRsell NATURES SUNSHINE PRODUCTS INC | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. owner | $33M 2,854,607 shares | -100% | |
| 17Weak | NATRsell NATURES SUNSHINE PRODUCTS INC | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. owner | $30k 2,300 shares | -3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.